DYmista NAsal Spray in CHInese Patients

Clinical trial NCT03599791 · COMPLETED

Trial details

NCT number: NCT03599791
Sponsor: MEDA Pharma GmbH & Co. KG
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2018-06-29
Primary completion: 2019-09-24
Enrollment: 900

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.